 ft 08 92 intern compani news chiron win fda approv cancer drug  chiron biotechnolog compani receiv approv food drug administr market interleukin 2 long await treatment aggress kidney cancer write louis keho san francisco approv mark end year struggl bring market wide regard promis product biotechnolog industri interleukin 2 sold brand proleukin 